Altered G1 signaling order and commitment point in cells proliferating without CDK4/6 activity

Area of Science:

• Cell Biology
• Molecular Biology
• Cancer Research

Background:

• Cell-cycle entry requires sequential signaling events, including cyclin D-CDK4/6 activation and retinoblastoma protein (Rb) inactivation.
• APC/C^CDH1 inactivation marks a later commitment point in the cell cycle.
• The precise mechanisms of cell-cycle entry, especially under conditions of CDK4/6 inhibition, remain poorly understood.

Purpose of the Study:

• To investigate how cells enter the cell cycle when CDK4/6 activity is inhibited.
• To determine if alternative cell-cycle entry pathways exist under normal physiological conditions.
• To elucidate the molecular steps and regulatory circuits involved in CDK4/6-independent cell-cycle progression.

Main Methods:

• Single-cell microscopy was employed to observe cell-cycle dynamics.
• Experiments were conducted on cell lines and wild-type mice.
• Key proteins and complexes, including cyclin D-CDK4/6, Rb, APC/C^CDH1, and cyclin E-CDK2, were monitored.

Main Results:

• Cells with acutely inhibited CDK4/6 exhibited slowed and fluctuating cyclin E-CDK2 activity during cell-cycle entry.
• A surprising reversal in the order of APC/C^CDH1 and Rb inactivation was observed under low CDK4/6 activity.
• Rb inactivation was identified as the new point of no return in this alternative pathway.

Conclusions:

• Cell-cycle entry can occur without canonical CDK4/6 activity through a pathway involving reversed signaling order.
• This demonstrates significant temporal plasticity within the G1 regulatory circuit.
• Findings have implications for understanding cancer resistance mechanisms and developing novel therapeutic strategies.